These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28975045)

  • 1. Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing.
    McCusker EA; Loy CT
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():467. PubMed ID: 28975045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-disclosure preimplantation genetic diagnosis for Huntington's disease: practical and ethical dilemmas.
    Braude PR; De Wert GM; Evers-Kiebooms G; Pettigrew RA; Geraedts JP
    Prenat Diagn; 1998 Dec; 18(13):1422-6. PubMed ID: 9949442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
    Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
    J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study.
    Beckmann H; Bohlen S; Saft C; Hoffmann R; Gerss J; Muratori L; Ringelstein EB; Landwehrmeyer GB; Reilmann R
    Gait Posture; 2018 May; 62():451-457. PubMed ID: 29660633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
    Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
    JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are schizophrenic patients being told their diagnosis today in France?].
    Villani M; Kovess-Masféty V
    Encephale; 2017 Apr; 43(2):160-169. PubMed ID: 27372353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Huntington disease.
    Margolis RL; Ross CA
    Clin Chem; 2003 Oct; 49(10):1726-32. PubMed ID: 14500613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive testing for Huntington disease and the right not to know. Some ethical reflections.
    de Wert G
    Birth Defects Orig Artic Ser; 1992; 28(1):133-8. PubMed ID: 1340223
    [No Abstract]   [Full Text] [Related]  

  • 10. The right to ignore genetic status of late onset genetic disease in the genomic era; Prenatal testing for Huntington disease as a paradigm.
    Erez A; Plunkett K; Sutton VR; McGuire AL
    Am J Med Genet A; 2010 Jul; 152A(7):1774-80. PubMed ID: 20583190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disclosures of Huntington disease risk within families: patterns of decision-making and implications.
    Klitzman R; Thorne D; Williamson J; Chung W; Marder K
    Am J Med Genet A; 2007 Aug; 143A(16):1835-49. PubMed ID: 17632780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis requests for Huntington's disease when the father is at risk and does not want to know his genetic status: clinical, legal, and ethical viewpoints.
    Tassicker R; Savulescu J; Skene L; Marshall P; Fitzgerald L; Delatycki MB
    BMJ; 2003 Feb; 326(7384):331-3. PubMed ID: 12574051
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program.
    Bloch M; Adam S; Fuller A; Kremer B; Welch JP; Wiggins S; Whyte P; Huggins M; Theilmann J; Hayden MR
    Am J Med Genet; 1993 Sep; 47(3):368-74. PubMed ID: 8135283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low utilization of prenatal and pre-implantation genetic diagnosis in Huntington disease - risk discounting in preventive genetics.
    Schulman JD; Stern HJ
    Clin Genet; 2015 Sep; 88(3):220-3. PubMed ID: 25307798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for the Huntington gene: a right to know, a right not to know, or a duty to know.
    Shaw MW
    Am J Med Genet; 1987 Feb; 26(2):243-6. PubMed ID: 2949608
    [No Abstract]   [Full Text] [Related]  

  • 16. Juvenile Huntington disease.
    Geevasinga N; Richards FH; Jones KJ; Ryan MM
    J Paediatr Child Health; 2006 Sep; 42(9):552-4. PubMed ID: 16925544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.
    Coppen EM; Jacobs M; van der Zwaan KF; Middelkoop HAM; Roos RAC
    Arch Clin Neuropsychol; 2019 Nov; 34(8):1320-1328. PubMed ID: 30796801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
    Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the hunt for a cure: A guide to Huntington disease.
    de la Cruz J; Hwang J
    JAAPA; 2021 Apr; 34(4):26-31. PubMed ID: 33735136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.